Aurobindo Pharma receives UK-MHRA clearance for Unit VIII

Aurobindo Pharma Ltd has announced that the UK-MHRA has issued a certificate of GMP Clearance for its Unit-VIII situated at Kazipally, near Hyderabad Andhra Pradesh. With this clearance, the API site completes one of the important formalities of supplies to be made in the European Union and observer states.

The certificate is also recognized by several other regulatory agencies and customers globally. The facility has already been inspected successfully in the past by US-FDA and WHO-Geneva as well.

The stock was trading at Rs.628, down by Rs.8.40 or 1.32%. The stock hit an intraday high of Rs.640 and low of Rs.626.10. The total traded quantity was 9408 compared to 2 week average of 22872.

Source : Equity Bulls

Keywords